Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Irreversible Electroporation (Nanoknife)
DEVICE
2 trials
Sponsors
Clinical Research Office of the Endourological Society
, University Health Network, Toronto
Conditions
Prostate Cancer
Phase 2
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer
NCT01835977
Clinical Research Office of the Endourological Society
Prostate Cancer
Start: 2015-06-30
End: 2025-01-31
Updated: 2020-12-16
Unknown Phase
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
Recruiting
NCT06451445
University Health Network, Toronto
Prostate Cancer
Start: 2024-05-16
End: 2033-05-01
Target: 100
Updated: 2026-06-11
Related Papers
Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control
JAMA Surgery
2023-02-01
29 citations
Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial.
2016-05-05
32 citations
The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
2015-08-22
47 citations
The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol
BMJ Open
2014-10-01
62 citations